Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy
出版年份 2021 全文链接
标题
Potential of helper-dependent Adenoviral vectors in CRISPR-cas9-mediated lung gene therapy
作者
关键词
-
出版物
Cell and Bioscience
Volume 11, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-24
DOI
10.1186/s13578-021-00662-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank
- (2020) Maarten H. Geurts et al. Cell Stem Cell
- A helper-dependent adenoviral vector rescues CFTR to wild type functional levels in CF epithelial cells harbouring class I mutations
- (2020) Huibi Cao et al. EUROPEAN RESPIRATORY JOURNAL
- Overcoming Immunological Challenges to Helper-Dependent Adenoviral Vector-Mediated Long-Term CFTR Expression in Mouse Airways
- (2020) Huibi Cao et al. Genes
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- In vitro validation of a CRISPR-mediated CFTR correction strategy for preclinical translation in pigs
- (2019) Zhichang Peter Zhou et al. HUMAN GENE THERAPY
- Gene and Base Editing as a Therapeutic Option for Cystic Fibrosis—Learning from Other Diseases
- (2019) Karen Mention et al. Genes
- Advances in gene therapy for cystic fibrosis lung disease
- (2019) Ziying Yan et al. HUMAN MOLECULAR GENETICS
- Stimulation of CRISPR-mediated homology-directed repair by an engineered RAD18 variant
- (2019) Tarun S. Nambiar et al. Nature Communications
- Efficient Gene Editing at Major CFTR Mutation Loci
- (2019) Jinxue Ruan et al. Molecular Therapy-Nucleic Acids
- Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors
- (2019) Chang Li et al. MOLECULAR THERAPY
- Transducing Airway Basal Cells with a Helper-Dependent Adenoviral Vector for Lung Gene Therapy
- (2018) Huibi Cao et al. HUMAN GENE THERAPY
- Optimized base editors enable efficient editing in cells, organoids and mice
- (2018) Maria Paz Zafra et al. NATURE BIOTECHNOLOGY
- CtIP fusion to Cas9 enhances transgene integration by homology-dependent repair
- (2018) M. Charpentier et al. Nature Communications
- Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction
- (2018) Emily Xia et al. Molecular Therapy-Nucleic Acids
- Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug
- (2017) Francesca Ferrua et al. HUMAN GENE THERAPY
- In vivo genome editing via the HITI method as a tool for gene therapy
- (2017) Keiichiro Suzuki et al. JOURNAL OF HUMAN GENETICS
- Cystic fibrosis: current therapeutic targets and future approaches
- (2017) Misbahuddin M. Rafeeq et al. Journal of Translational Medicine
- Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR–Cas9 genome-editing efficiency
- (2017) Marella D Canny et al. NATURE BIOTECHNOLOGY
- What can the CF registry tell us about rare CFTR-mutations? A Belgian study
- (2017) E. De Wachter et al. Orphanet Journal of Rare Diseases
- rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice
- (2016) Dragana Vidović et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Gene Therapy with Adeno-associated Virus for Cystic Fibrosis
- (2016) Rajvinder Karda et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Barriers to inhaled gene therapy of obstructive lung diseases: A review
- (2016) Namho Kim et al. JOURNAL OF CONTROLLED RELEASE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
- (2015) Bernd Zetsche et al. CELL
- Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Eric W F W Alton et al. Lancet Respiratory Medicine
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Targeted genome editing in human repopulating haematopoietic stem cells
- (2014) Pietro Genovese et al. NATURE
- Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification
- (2014) John P Guilinger et al. NATURE BIOTECHNOLOGY
- Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9
- (2014) Shota Nakade et al. Nature Communications
- Transduction of ferret airway epithelia using a pre-treatment and lentiviral gene vector
- (2014) Patricia Cmielewski et al. BMC Pulmonary Medicine
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- Moving forward: cystic fibrosis gene therapy
- (2013) U. Griesenbach et al. HUMAN MOLECULAR GENETICS
- High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
- (2013) Vikram Pattanayak et al. NATURE BIOTECHNOLOGY
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Personalized Medicine in Cystic Fibrosis
- (2012) John P. Clancy et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression
- (2012) Mrinal Srivastava et al. CELL
- Dry powder inhaler formulation of lipid–polymer hybrid nanoparticles via electrostatically-driven nanoparticle assembly onto microscale carrier particles
- (2012) Yue Yang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding
- (2011) Robert F. Ashman et al. INTERNATIONAL IMMUNOLOGY
- Common Gene Therapy Viral Vectors Do Not Efficiently Penetrate Sputum from Cystic Fibrosis Patients
- (2011) Kaoru Hida et al. PLoS One
- Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling
- (2010) J. R. Rock et al. Disease Models & Mechanisms
- Collaboration and competition between DNA double-strand break repair pathways
- (2010) Elizabeth M. Kass et al. FEBS LETTERS
- Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression
- (2010) H Cao et al. GENE THERAPY
- Adenoviral vectors stimulate innate immune responses in macrophages through cross-talk with epithelial cells
- (2010) Benjamin H. Lee et al. IMMUNOLOGY LETTERS
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Airway Mucus Function and Dysfunction
- (2010) John V. Fahy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving Adenovirus Based Gene Transfer: Strategies to Accomplish Immune Evasion
- (2010) Sergey S. Seregin et al. Viruses-Basel
- Myeloid RelA regulates pulmonary host defense networks
- (2009) C. Hess et al. EUROPEAN RESPIRATORY JOURNAL
- Pre-existing Immunity and Passive Immunity to Adenovirus 5 Prevents Toxicity Caused by an Oncolytic Adenovirus Vector in the Syrian Hamster Model
- (2009) Debanjan Dhar et al. MOLECULAR THERAPY
- Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy
- (2009) Sergey S Seregin et al. MOLECULAR THERAPY
- Basal cells as stem cells of the mouse trachea and human airway epithelium
- (2009) J. R. Rock et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium
- (2009) Liqun Zhang et al. PLOS BIOLOGY
- Barrier properties of mucus
- (2008) Richard A. Cone ADVANCED DRUG DELIVERY REVIEWS
- Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors
- (2008) N Brunetti-Pierri et al. GENE THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More